// App-Quantinova.ai

6535 : A recombinant Newcastle disease virus expressing IL-12 has potent pre-clinical immunomodulatory and anti tumor properties

Researchers

Presenter

  • James Harper

Principal Investigators

  • Andrew Leinster

  • Nicola Rath

  • Shannon Burke

  • Kathy Mulgrew

  • Hong Jin

  • Robert W. Wilkinson

Medical Centers

  • AstraZeneca, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Interleukin 12

Drug/Treatment

  • Interferon

  • IL-12

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved